Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry

This paper investigates the effect of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes driven by U.S. demographic trends, we find that a 1 percent increase in the potential market size for a drug category leads to a 4 to 6 percent increase in the number of new drugs in that category. This response comes from both the entry of generic drugs and new non-generic drugs, and is generally robust to controlling for a variety of non-profit factors, pre-existing trends

[1]  Stefano DellaVigna,et al.  Attention, Demographics, and the Stock Market , 2005 .

[2]  Amy N. Finkelstein.  Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry , 2004 .

[3]  R. Cerda.  LABOR MARKET AND UNEMPLOYMENT , 2003 .

[4]  Jeffrey M. Wooldridge,et al.  Solutions Manual and Supplementary Materials for Econometric Analysis of Cross Section and Panel Data , 2003 .

[5]  F. Lichtenberg.  The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 , 2003, International Journal of Health Care Finance and Economics.

[6]  F. Lichtenberg,et al.  Does Misery Love Company? Evidence from Pharmaceutical Markets Before and after the Orphan Drug Act , 2003 .

[7]  P. Danzon,et al.  Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances , 2003, Journal of health economics.

[8]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[9]  Michael R. Ward,et al.  Generic Drug Industry Dynamics , 2002, Review of Economics and Statistics.

[10]  Franco Malerba,et al.  Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history‐friendly model , 2002 .

[11]  I. Cockburn,et al.  Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research. , 2001, Journal of health economics.

[12]  David Popp,et al.  Induced Innovation and Energy Prices , 2001 .

[13]  D. Acemoglu.  Directed Technical Change , 2001 .

[14]  F. Lichtenberg.  Sources of U.S. Longevity Increase, 1960 - 1997 , 2000, SSRN Electronic Journal.

[15]  D. Acemoglu.  Labor- and Capital- Augmenting Technical Change , 2000 .

[16]  P. Howitt,et al.  Endogenous Growth Theory , 1999 .

[17]  Scott Stern,et al.  The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research , 1999 .

[18]  F. Morton,et al.  Entry decisions in the generic pharmaceutical industry. , 1999, The Rand journal of economics.

[19]  J. Wooldridge.  Distribution-free estimation of some nonlinear panel data models , 1999 .

[20]  D. Acemoglu.  Why Do New Technologies Complement Skills? Directed Technical Change and Wage Inequality , 1998 .

[21]  R. Blundell,et al.  Initial Conditions and Moment Restrictions in Dynamic Panel Data Models , 1998 .

[22]  Louis Galambos,et al.  Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation , 1998, Business History Review.

[23]  A. Jaffe,et al.  The Induced Innovation Hypothesis and Energy-Saving Technological Change , 1998 .

[24]  F. Lichtenberg.  The Allocation of Publicly-Funded Biomedical Research , 1997 .

[25]  Z. Griliches,et al.  Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs , 1997 .

[26]  B. Spilker,et al.  Science and Innovation: The US Pharmaceutical Industry During the 1980s , 1996 .

[27]  M. Arellano,et al.  Another look at the instrumental variable estimation of error-components models , 1995 .

[28]  David O. Meltzer,et al.  Do Important Drugs Reach the Market Sooner , 1994 .

[29]  G. Grossman,et al.  Innovation and growth in the global economy , 1993 .

[30]  David E. Nye,et al.  Electrifying America: Social Meanings of a New Technology , 1992 .

[31]  L Lasagna,et al.  Cost of innovation in the pharmaceutical industry. , 1991, Journal of health economics.

[32]  Z. Griliches,et al.  Econometric Models for Count Data with an Application to the Patents-R&D Relationship , 1984 .

[33]  Paul A. David,et al.  Technical Choice Innovation and Economic Growth: Essays on American and British Experience in the Nineteenth Century , 1975 .

[34]  N. Rosenberg.  Science, Invention and Economic Growth , 1974 .

[35]  Vernon W. Ruttan,et al.  Factor Prices and Technical Change in Agricultural Development: The United States and Japan, 1880-1960 , 1970, Journal of Political Economy.

[36]  Jacob Schmookler,et al.  Invention and Economic Growth , 1967 .

[37]  E. Drandakis,et al.  A Model of Induced Invention, Growth and Distribution , 1966 .

[38]  Syed Ahmad,et al.  On the Theory of Induced Invention , 1966 .

[39]  Paul A. Samuelson,et al.  A Theory of Induced Innovation along Kennedy-Weisacker Lines , 1965 .

[40]  C. Kennedy,et al.  Induced Bias in Innovation and the Theory of Distribution , 1964 .

[41]  K. Arrow.  The Economic Implications of Learning by Doing , 1962 .

[42]  Z. Griliches.  HYBRID CORN: AN EXPLORATION IN THE ECONOMIC OF TECHNOLOGICAL CHANGE , 1957 .

[43]  Bart Verspagen,et al.  Patents, citations, and innovations , 2004 .

[44]  R. Cerda.  Drugs, market size and population. , 2003 .

[45]  Michael Kremer,et al.  Pharmaceuticals and the developing world. , 2002, The journal of economic perspectives : a journal of the American Economic Association.

[46]  F. Lichtenberg.  The Effects of Medicare on Health Care Utilization and Outcomes , 2002 .

[47]  Jeffrey M. Woodbridge.  Econometric Analysis of Cross Section and Panel Data , 2002 .

[48]  Paul E. Ceruzzi,et al.  A history of modern computing , 1999 .

[49]  I. Cockburn,et al.  Scale, scope, and spillovers: the determinants of research productivity in drug discovery. , 1996, The Rand journal of economics.

[50]  A. Pakes,et al.  Patents and R&D at the Firm Level: A First Look , 1984 .

[51]  F. Scherer.  Innovation and growth , 1984 .

[52]  Ariel Pakes,et al.  An Exploration into the Determinants of Research Intensity , 1980 .

[53]  Zvi Griliches,et al.  Patents and R&D at the firm level: A first report , 1980 .

[54]  P. Romer.  Endogenous Technological Change Endogenous Technological Change , 2022 .